GO:1990550 mitochondrial alpha-ketoglutarate transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990550 describes the biological process by which alpha-ketoglutarate (2-oxoglutarate) is transported across the mitochondrial membrane, into or out of the mitochondrion [3,5].
• The mitochondrial oxoglutarate carrier (OGC, SLC25A11) is the primary transporter responsible for this process, exchanging alpha-ketoglutarate for malate or other dicarboxylates [3,5,6].
• Structural studies using site-directed spin labeling and cysteine-scanning mutagenesis have mapped key transmembrane helices (IV, V, VI) that form the substrate translocation pathway [3,5,7,8].
• Alpha-ketoglutarate transport is critical for the malate-aspartate shuttle, nitrogen metabolism, and the tricarboxylic acid (TCA) cycle, linking mitochondrial and cytosolic metabolic pathways [2,3].
• Dysregulation of mitochondrial alpha-ketoglutarate transport has been implicated in mitochondrial disorders and metabolic reprogramming in cancer [2,4].
• Researchers study this process using knockout, point-mutation, and overexpression cell models, combined with metabolic flux analysis and structural techniques [3,5,6].
Description
Mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550) is a fundamental biological process that mediates the movement of alpha-ketoglutarate (also known as 2-oxoglutarate) across the inner mitochondrial membrane [3,5]. This transport is essential for maintaining metabolic homeostasis, as alpha-ketoglutarate serves as a key intermediate in the TCA cycle and a substrate for numerous biosynthetic and signaling reactions [2,3]. The process is primarily carried out by the mitochondrial oxoglutarate carrier (OGC), a member of the mitochondrial carrier family (SLC25A11), which catalyzes an electroneutral exchange of alpha-ketoglutarate for malate or other dicarboxylates [3,5,6]. Researchers study GO:1990550 to understand how mitochondrial and cytosolic metabolic fluxes are coordinated, particularly in the context of the malate-aspartate shuttle, nitrogen assimilation, and redox balance [2,3]. The carrier's activity is critical for supplying alpha-ketoglutarate to the cytosol for amino acid synthesis and for importing it into mitochondria for energy production [2,6]. Structural and functional studies have revealed that specific transmembrane helices, such as helices IV, V, and VI, are essential for substrate binding and translocation [3,5,7,8]. Dysregulation of mitochondrial alpha-ketoglutarate transport has been linked to mitochondrial disorders and cancer metabolism, making it a target of interest for therapeutic development [2,4]. Understanding the molecular details of this process provides insights into how cells adapt to metabolic stress and how mutations in carrier proteins contribute to disease [2,4].
mitochondrial alpha-ketoglutarate transmembrane transport At A Glance
| GO ID | GO:1990550 |
|---|---|
| GO term | mitochondrial alpha-ketoglutarate transmembrane transport |
| Ontology | biological_process |
| Synonym | mitochondrial 2-oxoglutarate transmembrane transport |
| Major function | Transport of alpha-ketoglutarate across the mitochondrial membrane |
| Major transporter | Mitochondrial oxoglutarate carrier (OGC, SLC25A11) |
| Subcellular location | Inner mitochondrial membrane |
| Directionality | Into or out of the mitochondrion |
| Related process | Malate-aspartate shuttle, TCA cycle, nitrogen metabolism |
What Is GO:1990550?
GO:1990550, mitochondrial alpha-ketoglutarate transmembrane transport, is defined as the process in which alpha-ketoglutarate is transported across a mitochondrial membrane, into or out of the mitochondrion. This process is mediated by specific carrier proteins embedded in the inner mitochondrial membrane and is essential for shuttling this key metabolite between mitochondrial and cytosolic compartments [3,5].
Why Is mitochondrial alpha-ketoglutarate transmembrane transport Important in Cell Biology?
Mitochondrial alpha-ketoglutarate transmembrane transport is crucial for cellular metabolism because alpha-ketoglutarate is a central node connecting the TCA cycle, amino acid metabolism, and redox regulation [2,3]. The transport process enables the exchange of alpha-ketoglutarate with malate, which is essential for the malate-aspartate shuttle that transfers reducing equivalents from the cytosol to the mitochondria [2,3]. This shuttle is vital for maintaining cytosolic and mitochondrial redox balance and for supporting oxidative phosphorylation. Additionally, alpha-ketoglutarate serves as a co-substrate for dioxygenases involved in epigenetic regulation and hypoxia sensing, and its transport affects the availability of this metabolite in different cellular compartments. Defects in the carrier protein have been associated with mitochondrial disorders, highlighting its clinical importance.
• Maintains the malate-aspartate shuttle, which is essential for cytosolic NADH oxidation and mitochondrial energy production.
• Supplies alpha-ketoglutarate for cytosolic amino acid synthesis, including glutamate and glutamine [2,3].
• Regulates mitochondrial TCA cycle flux by controlling substrate availability.
• Influences cellular redox homeostasis through exchange with malate.
• Plays a role in nitrogen metabolism and ammonia detoxification.
• Dysregulation is linked to mitochondrial disorders and metabolic diseases.
• Alterations in transport activity contribute to cancer metabolic reprogramming.
• Provides a target for studying mitochondrial carrier structure-function relationships [3,5,6,7,8].
• Essential for normal mitochondrial function and cellular adaptation to metabolic stress [2,4].
• Impacts epigenetic regulation by modulating alpha-ketoglutarate availability.
What Happens During mitochondrial alpha-ketoglutarate transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs alpha-ketoglutarate on one side of the mitochondrial membrane.
The mitochondrial oxoglutarate carrier (OGC) binds alpha-ketoglutarate with high specificity. Structural studies using site-directed spin labeling and cysteine-scanning mutagenesis have identified key residues in transmembrane helices IV, V, and VI that form the substrate binding pocket [3,5,7,8]. In particular, helix IV contains residues critical for substrate recognition, as mutations in this region alter transport activity [3,7]. The binding site is thought to undergo conformational changes upon substrate interaction, facilitating the translocation process [5,8].
Conformational Change and Translocation
In simple terms: The transporter changes shape to move alpha-ketoglutarate across the membrane.
Upon substrate binding, the OGC undergoes a conformational transition that opens a pathway through the membrane. Site-directed spin labeling studies have revealed dynamic movements in transmembrane segments IV and VI during the transport cycle [5,8]. The carrier operates via an alternating access mechanism, where the substrate binding site is exposed alternately to the mitochondrial matrix and the intermembrane space [3,6]. This process is electroneutral, as alpha-ketoglutarate is exchanged for a dicarboxylate such as malate, maintaining charge balance.
Exchange with Malate or Other Dicarboxylates
In simple terms: Alpha-ketoglutarate is swapped with another molecule, usually malate, in a one-for-one exchange.
The OGC catalyzes a strict exchange of alpha-ketoglutarate for malate or other dicarboxylates, rather than a unidirectional transport [3,6]. This exchange is essential for the malate-aspartate shuttle, which transfers reducing equivalents from the cytosol to the mitochondrial matrix. The stoichiometry is 1:1, and the process is not dependent on membrane potential, distinguishing it from other mitochondrial carriers. Mutagenesis studies have shown that residues in the matrix alpha-helices and cytosolic loops contribute to substrate specificity and exchange efficiency.
Release and Reset
In simple terms: After delivering alpha-ketoglutarate, the transporter resets to pick up another molecule.
Following the exchange, alpha-ketoglutarate is released on the opposite side of the membrane, and the carrier returns to its initial conformation to repeat the cycle [5,8]. This reset step is crucial for continuous transport and is influenced by the lipid environment and specific amino acid residues in the transmembrane domains [3,5]. Studies on the odd-numbered transmembrane alpha-helices have highlighted the importance of helix V in the reset mechanism.
Key Genes Involved in GO:1990550 mitochondrial alpha-ketoglutarate transmembrane transport
The following genes and proteins are directly involved in or regulate mitochondrial alpha-ketoglutarate transmembrane transport.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A11 | Encodes the mitochondrial oxoglutarate carrier (OGC), the primary transporter for alpha-ketoglutarate across the inner mitochondrial membrane | Central to studies of transport mechanism, structure-function, and disease associations [3,5,6,7,8] |
| SLC25A1 | Mitochondrial citrate carrier, indirectly affects alpha-ketoglutarate levels by transporting citrate | Studied in context of metabolic flux and TCA cycle intermediates |
| SLC25A12 | Mitochondrial aspartate/glutamate carrier, component of malate-aspartate shuttle | Relevant for understanding coupled transport with OGC |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier, component of malate-aspartate shuttle | Relevant for understanding coupled transport with OGC |
| MDH2 | Malate dehydrogenase, produces malate for exchange with alpha-ketoglutarate | Studied for its role in supplying substrate to OGC |
| GOT2 | Glutamate oxaloacetate transaminase, generates alpha-ketoglutarate in mitochondria | Linked to OGC substrate availability |
| GOT1 | Glutamate oxaloacetate transaminase, generates alpha-ketoglutarate in cytosol | Linked to OGC substrate availability |
| GDH1 | Glutamate dehydrogenase, produces alpha-ketoglutarate from glutamate | Affects alpha-ketoglutarate pool for transport |
| GDH2 | Glutamate dehydrogenase, produces alpha-ketoglutarate from glutamate | Affects alpha-ketoglutarate pool for transport |
| SFXN1 | Mitochondrial carrier involved in serine metabolism, may influence alpha-ketoglutarate levels | Studied for broader mitochondrial carrier functions |
| IDH2 | Isocitrate dehydrogenase, produces alpha-ketoglutarate in mitochondria | Source of mitochondrial alpha-ketoglutarate for transport |
| IDH1 | Isocitrate dehydrogenase, produces alpha-ketoglutarate in cytosol | Cytosolic source of alpha-ketoglutarate |
| OGDH | Alpha-ketoglutarate dehydrogenase, consumes alpha-ketoglutarate in TCA cycle | Competes with transport for alpha-ketoglutarate |
| DLST | Dihydrolipoamide succinyltransferase, component of OGDH complex | Affects alpha-ketoglutarate utilization |
| SLC25A10 | Mitochondrial dicarboxylate carrier, can transport malate and other dicarboxylates | Potential alternative or complementary transporter |
| SLC25A18 | Mitochondrial glutamate carrier, indirectly affects alpha-ketoglutarate via glutamate metabolism | Studied in context of nitrogen metabolism |
| SLC25A22 | Mitochondrial glutamate carrier, indirectly affects alpha-ketoglutarate via glutamate metabolism | Studied in context of nitrogen metabolism |
How Is mitochondrial alpha-ketoglutarate transmembrane transport Regulated?
The activity of the mitochondrial oxoglutarate carrier (OGC) is regulated at multiple levels. Expression of SLC25A11 is tissue-specific, with higher levels in tissues with active malate-aspartate shuttle, such as heart and liver. The transport activity is influenced by the availability of substrates (alpha-ketoglutarate and malate) and by the redox state of the cell. Structural studies suggest that specific amino acid residues, particularly cysteines in transmembrane domain IV, can modulate carrier function through redox-dependent modifications. Additionally, the lipid composition of the inner mitochondrial membrane may affect carrier dynamics and activity. However, direct transcriptional or post-translational regulation of OGC is not well characterized, and further research is needed to fully understand its regulatory mechanisms [3,6].
mitochondrial alpha-ketoglutarate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A11 | Mitochondrial disorders, metabolic imbalance | Knockout and point-mutation cell models to assess transport activity and metabolic flux |
| SFXN1 | Cancer metabolism, complex III integrity | Knockout and overexpression models to study mitochondrial function |
| IDH1/IDH2 | Cancer, metabolic reprogramming | Point mutations to alter alpha-ketoglutarate production and transport coupling |
| MDH2 | Mitochondrial disorders, cancer | Knockout models to disrupt malate-aspartate shuttle |
| GOT2 | Metabolic disorders, cancer | Knock-in of tagged versions to track alpha-ketoglutarate flux |
Mitochondrial Disorders
Mutations in mitochondrial carrier proteins, including the oxoglutarate carrier, have been associated with mitochondrial disorders. Defects in SLC25A11 can impair the malate-aspartate shuttle, leading to reduced energy production and metabolic imbalances. Although specific mutations in SLC25A11 are rare, its dysfunction contributes to the broader spectrum of mitochondrial disease phenotypes.
Cancer Metabolism
Alterations in alpha-ketoglutarate transport affect cancer cell metabolism by modulating the availability of alpha-ketoglutarate for biosynthetic pathways and epigenetic regulation. The mitochondrial carrier SFXN1, which influences alpha-ketoglutarate levels, has been shown to be critical for complex III integrity and cellular metabolism, suggesting a role in cancer cell survival. Targeting alpha-ketoglutarate transport may offer therapeutic opportunities in cancers with metabolic vulnerabilities.
Neurological Implications
The malate-aspartate shuttle is essential for neuronal energy metabolism, and its dysfunction has been implicated in neurodegenerative conditions. Although direct links between OGC mutations and neurological diseases are not well established, impaired alpha-ketoglutarate transport could contribute to neuronal vulnerability under metabolic stress.
From mitochondrial alpha-ketoglutarate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of SLC25A11 loss on mitochondrial alpha-ketoglutarate transport? | SLC25A11 knockout cell line (e.g., HEK293T, HeLa) |
| How do specific point mutations in SLC25A11 affect substrate binding? | Point-mutation knock-in models (e.g., SLC25A11 C184S) |
| Can we visualize OGC localization and dynamics in live cells? | Knock-in of fluorescent tags (e.g., GFP-SLC25A11) |
| Does overexpression of SLC25A11 alter metabolic flux? | SLC25A11 overexpression cell lines |
| What are the compensatory changes upon OGC loss? | CRISPR library screening for synthetic lethality |
| How does OGC interact with other mitochondrial carriers? | Proximity labeling (BioID) with tagged SLC25A11 |
How to Study the mitochondrial alpha-ketoglutarate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C Metabolic Flux Analysis | Flux of alpha-ketoglutarate through metabolic pathways | Quantifying transport activity in knockout vs. wild-type cells |
| Site-Directed Spin Labeling EPR | Conformational changes of OGC during transport | Mapping dynamic movements of transmembrane helices [5,8] |
| Cysteine-Scanning Mutagenesis | Accessibility and functional role of specific residues | Identifying substrate binding sites in OGC |
| CRISPR-Cas9 Knockout | Loss-of-function effects on transport and metabolism | Studying SLC25A11 in mitochondrial function |
| CRISPR-Cas9 Knock-in | Tagged protein localization and interaction | Visualizing OGC in live cells |
| Proteomics | Protein expression and interaction networks | Identifying OGC binding partners |
| RNA-seq | Transcriptional changes upon transport perturbation | Assessing compensatory gene expression |
| Seahorse XF Analyzer | Mitochondrial respiration and glycolysis | Measuring metabolic phenotype of transport mutants |
Metabolic Flux Analysis
Metabolic flux analysis using 13C-labeled substrates can quantify the rate of alpha-ketoglutarate transport and its contribution to the TCA cycle. By tracing labeled carbons, researchers can assess how genetic perturbations in SLC25A11 affect metabolic pathways [3,4].
Site-Directed Spin Labeling and EPR Spectroscopy
Site-directed spin labeling combined with electron paramagnetic resonance (EPR) spectroscopy allows researchers to study conformational dynamics of the oxoglutarate carrier in real time. This technique has been used to map the movement of transmembrane helices during transport [5,8].
Cysteine-Scanning Mutagenesis
Cysteine-scanning mutagenesis involves substituting amino acids with cysteine to probe the accessibility and function of specific residues. This method has identified critical residues in transmembrane domain IV of OGC that are involved in substrate binding and transport.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 knockout, knock-in, and point-mutation models enable precise manipulation of genes involved in alpha-ketoglutarate transport. These models are used to study the consequences of loss or alteration of carrier function on cellular metabolism and disease phenotypes.
How CRISPR Can Be Used to Study GO:1990550 mitochondrial alpha-ketoglutarate transmembrane transport
Knockout
CRISPR-Cas9 knockout of SLC25A11 generates cell lines lacking the mitochondrial oxoglutarate carrier, enabling researchers to study the consequences of loss of alpha-ketoglutarate transport on mitochondrial metabolism, redox balance, and cellular growth. These models are essential for validating the carrier's role in the malate-aspartate shuttle and identifying compensatory pathways.
Point Mutation
Point mutations in SLC25A11 can be introduced using CRISPR-Cas9 homology-directed repair to mimic disease-associated variants or to probe structure-function relationships. For example, mutations in cysteine residues of transmembrane domain IV can alter transport activity and sensitivity to sulfhydryl reagents. These models help dissect the molecular basis of substrate recognition and translocation.
Knock-in
Knock-in of fluorescent or affinity tags (e.g., GFP, HA) into the endogenous SLC25A11 locus allows for real-time visualization and biochemical isolation of the oxoglutarate carrier. Tagged knock-in models are valuable for studying protein localization, dynamics, and interactions with other mitochondrial proteins [5,8].
Overexpression
Overexpression of SLC25A11 using CRISPR activation or lentiviral delivery can increase alpha-ketoglutarate transport capacity, enabling studies on metabolic flux and the effects of enhanced transport on cellular physiology. Overexpression models are useful for testing whether increased carrier activity alters TCA cycle intermediates and biosynthetic pathways.
How EDITGENE Supports mitochondrial alpha-ketoglutarate transmembrane transport Research
Researchers studying mitochondrial alpha-ketoglutarate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to create precise cell models that enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial alpha-ketoglutarate transmembrane transport research.
Frequently Asked Questions About mitochondrial alpha-ketoglutarate transmembrane transport
What is mitochondrial alpha-ketoglutarate transmembrane transport?
It is the biological process (GO:1990550) by which alpha-ketoglutarate is transported across the mitochondrial membrane, into or out of the mitochondrion, primarily mediated by the oxoglutarate carrier [3,5].
What genes are involved in mitochondrial alpha-ketoglutarate transmembrane transport?
The primary gene is SLC25A11, which encodes the mitochondrial oxoglutarate carrier. Other genes such as MDH2, GOT2, and IDH2 influence substrate availability [2,3].
Which protein carries alpha-ketoglutarate across the mitochondrial membrane?
The mitochondrial oxoglutarate carrier (OGC), encoded by SLC25A11, is the main transporter that exchanges alpha-ketoglutarate for malate [3,5,6].
How is mitochondrial alpha-ketoglutarate transport studied?
Researchers use metabolic flux analysis, site-directed spin labeling, cysteine-scanning mutagenesis, and CRISPR-Cas9 knockout/knock-in models [3,5,7,8].
What diseases are associated with defects in alpha-ketoglutarate transport?
Defects have been linked to mitochondrial disorders and cancer metabolic reprogramming [2,4].
What is the role of the malate-aspartate shuttle in alpha-ketoglutarate transport?
The shuttle relies on the exchange of alpha-ketoglutarate for malate to transfer reducing equivalents from the cytosol to mitochondria.
Can CRISPR be used to study mitochondrial alpha-ketoglutarate transport?
Yes, CRISPR-Cas9 can create knockout, point-mutation, knock-in, and overexpression models to dissect the function of SLC25A11 and related genes.
What are the synonyms for mitochondrial alpha-ketoglutarate transmembrane transport?
The synonym is mitochondrial 2-oxoglutarate transmembrane transport.
What is the GO ID for mitochondrial alpha-ketoglutarate transmembrane transport?
The GO ID is GO:1990550.
Why is alpha-ketoglutarate transport important for cell metabolism?
It maintains the malate-aspartate shuttle, supplies substrates for biosynthesis, and regulates TCA cycle flux and redox balance [2,3].
Conclusion
Mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550) is a vital biological process that ensures the proper distribution of a key metabolic intermediate between mitochondria and the cytosol. The oxoglutarate carrier SLC25A11 mediates this transport through a sophisticated exchange mechanism that is essential for the malate-aspartate shuttle, nitrogen metabolism, and cellular redox homeostasis [2,3,5]. Structural and functional studies have provided detailed insights into the residues and conformational changes that drive transport [3,5,6,7,8]. Dysregulation of this process has implications for mitochondrial disorders and cancer, making it a compelling target for further research [2,4]. Advances in CRISPR-based genome editing and metabolic analysis continue to unravel the complexities of this transport system, offering potential for therapeutic intervention. EDITGENE's services support these investigations by providing precise cell models tailored to study mitochondrial alpha-ketoglutarate transport.
References
- 2. Huizing M et al.. 1998. Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders.. J Bioenerg Biomembr 30(3):277-84 PMID: 9733094
- 3. Cappello AR et al.. 2007. Functional and structural role of amino acid residues in the odd-numbered transmembrane alpha-helices of the bovine mitochondrial oxoglutarate carrier.. J Mol Biol 369(2):400-12 PMID: 17442340
- 4. Acoba MG et al.. 2021. The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism.. Cell Rep 34(11):108869 PMID: 33730581
- 5. Morozzo della Rocca B et al.. 2003. The mitochondrial oxoglutarate carrier: structural and dynamic properties of transmembrane segment IV studied by site-directed spin labeling.. Biochemistry 42(18):5493-9 PMID: 12731891
- 6. Miniero DV et al.. 2011. Functional and structural role of amino acid residues in the matrix alpha-helices, termini and cytosolic loops of the bovine mitochondrial oxoglutarate carrier.. Biochim Biophys Acta 1807(3):302-10 PMID: 21167128
- 7. Stipani V et al.. 2001. The mitochondrial oxoglutarate carrier: cysteine-scanning mutagenesis of transmembrane domain IV and sensitivity of Cys mutants to sulfhydryl reagents.. Biochemistry 40(51):15805-10 PMID: 11747458
- 8. Lauria G et al.. 2008. Structural-dynamical properties of the transmembrane segment VI of the mitochondrial oxoglutarate carrier studied by site directed spin-labeling.. Mol Membr Biol 25(3):236-44 PMID: 18428039
